Ji-Ln Kim

Title: Ji-Ln Kim: Innovator in Infectious Disease Treatment

Introduction

Ji-Ln Kim is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of infectious diseases. His innovative approach focuses on the use of glucose uptake inhibitors to combat various infectious diseases.

Latest Patents

Ji-Ln Kim holds a patent for a method of treating infectious diseases in mammals. This patent, titled "Treatment of infectious diseases with glucose uptake inhibitors," outlines methods for administering compounds that inhibit glucose uptake. The treatment targets infectious diseases such as malaria, leishmaniasis, African trypanosomiasis, tuberculosis, HIV, HCMV, and herpes virus. The invention emphasizes the administration of a therapeutically effective amount of a compound or prodrug, or a pharmaceutically acceptable salt or ester of said compound or prodrug.

Career Highlights

Ji-Ln Kim is associated with Kadmon Corporation, LLC, where he continues to work on innovative solutions for infectious diseases. His research and development efforts have positioned him as a key figure in the medical community, particularly in the area of infectious disease treatment.

Collaborations

Some of Ji-Ln Kim's coworkers include Kellen L Olszewski and Masha V Poyurovsky. Their collaborative efforts contribute to the advancement of research and development in the field of medicine.

Conclusion

Ji-Ln Kim's work in developing treatments for infectious diseases through glucose uptake inhibitors showcases his dedication to improving health outcomes. His innovative contributions are vital in the ongoing fight against infectious diseases.